J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, J. T.
Right arrow Articles by Springer, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, J. T.
Right arrow Articles by Springer, M. A.

THERAPEUTIC REVIEW

Role of the Research-Subject Locator (RSL) in the Performance of a Pediatric Drug Trial

J. T. Wilson, MD, G. Kearns, PharmD, PhD and M. A. Springer, MD

From the Department of Pediatrics, LSU Health Sciences Center, Shreveport, Louisiana (Dr. Wilson, Dr. Springer) and the Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri (Dr. Kearns).

This article examines the feasibility, effectiveness, and ethical constraints relevant to appropriate financial compensation of the pediatric house officer who functions as a research-subject locator (RSL). When carefully trained and supervised, the RSL can facilitate timely enrollment of research subjects in pediatric drug trials, augment the house officer training experience, and advocate for children to increase therapeutic options available for pediatric care. When monitored within the clinical trial schema, the RSL has no direct link to the study outcome and thus performs within ethical standards for subject enrollment and study participation.


Key Words: Research-subject locatorpediatricsclinical trialspatient recruitment

Address for reprints: John T. Wilson, MD, Section on Clinical Pharmacology, Department of Pediatrics, Children's Hospital, LSUHSC-Shreveport, P.O. Box 33932, Room B-5-243, Shreveport, LA 71130.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Clinical Pharmacology